# Trial of Combination Therapy to Treat COVID-19 Infection

> **NCT04482686** · PHASE1 · COMPLETED · sponsor: **ProgenaBiome** · enrollment: 31 (actual)

## Conditions studied

- COVID
- Covid-19
- Corona Virus Infection
- Coronavirus Infection
- Coronavirus-19
- SARS-CoV2
- SARS-CoV Infection

## Interventions

- **DRUG:** Ivermectin
- **DRUG:** Doxycycline Hcl
- **DIETARY_SUPPLEMENT:** Zinc
- **DIETARY_SUPPLEMENT:** Vitamin D3
- **DIETARY_SUPPLEMENT:** Vitamin C

## Key facts

- **NCT ID:** NCT04482686
- **Lead sponsor:** ProgenaBiome
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-12-09
- **Primary completion:** 2022-05-15
- **Final completion:** 2022-07-15
- **Target enrollment:** 31 (ACTUAL)
- **Last updated:** 2024-09-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04482686

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04482686, "Trial of Combination Therapy to Treat COVID-19 Infection". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04482686. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*